A new pathway for the transformation of AML in MDS: APA mechanism regulated by NUDT21 and RUNX1

We have identified that NUDT21 plays a vital role in MDS transformations, while the transcription factor RUNX1 is essential for normal hematopoiesis, which is a high expression in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and we aim to explore the linkage between the two genes and new pathways for MDS transformation to AML.Prediction of RUNX1 expression levels and its relationship with NUDT21 in AML and MDS patients was performed using bioinformatics techniques and validated in patients.Using lentiviral packaging technology, NUDT21 knockdown and overexpression models were developed in AML and MDS cell lines.These models were validated using quantitative polymerase chain reaction (qPCR) and western blotting.The cell cycle, apoptosis, differentiation, and cytokines were examined by flow cytometry, CCK-8 analyzed proliferation, and the intracellular localization of NUDT21 and RUNX1 was examined by immunofluorescence.mRNA transcriptome sequencing was performed on THP-1, MUTZ-1, and Dapars analyzed SKM-1 cell lines and the sequencing data to observe the knockdown effect of NUDT21 on RUNX1.qPCR and western blot revealed a positive correlation between NUDT21 and RUNX1; both were located in the nucleus.Overexpression of NUDT21 reduced apoptosis, promoted cell proliferation, and possibly increased the invasive ability of cells.It also altered the APA site in the RUNX1 3'-UTRs region.NUDT21 regulates RUNX1 gene expression and promotes AML transformation in MDS through an APA mechanism.